অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 8 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; povidone; maize starch; magnesium stearate - for the temporary relief of acute moderate pain and fever in patients over the age of 18 years.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 6 mg; phenylephrine hydrochloride, quantity: 5 mg - tablet, uncoated - excipient ingredients: purified water; magnesium stearate; microcrystalline cellulose; maize starch; colloidal anhydrous silica; hyprolose; povidone - temporary symptomatic relief of headache, myalgia, fever, nasal congestion and rhinorrhoea in patients aged 12 years and older.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - phenylephrine hydrochloride, quantity: 5 mg; paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 9.5 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; magnesium stearate; maize starch; microcrystalline cellulose; colloidal anhydrous silica; povidone; crospovidone; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - for the temporary relief from symptoms of colds and flu, including runny nose, nasal congestion, headache and body aches and pains. reduces fever.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 15 mg - tablet, uncoated - excipient ingredients: purified water; povidone; potato starch; ethanol; docusate sodium; magnesium stearate; lactose monohydrate; colloidal anhydrous silica - for temporary relief of acute moderate pain.

মাল্টা - ইংরেজি - Medicines Authority

alfred gera & sons limited 10 triq il-masgar, qormi qrm3217, malta - paracetamol, codeine phosphate, hemihydrate - film-coated tablet - paracetamol 500 mg codeine phosphate hemihydrate 12.8 mg - analgesics

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - codeine phosphate hemihydrate 50 mg/ml;   - solution for injection - 50 mg/ml - active: codeine phosphate hemihydrate 50 mg/ml   excipient: sodium chloride water for injection

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - codeine phosphate hemihydrate 5 mg/ml;   - oral solution - 25 mg/5ml - active: codeine phosphate hemihydrate 5 mg/ml   excipient: ethanol methyl hydroxybenzoate sucrose water

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - codeine phosphate 10 mg in 5 ml - promethazine with codeine syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. the combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age, because the combination may cause fatal respiratory depression in this age population. codeine is contraindicated in patients with a known hypersensitivity to the drug. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines and codeine are both contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. the combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age. concomitant administration of promethazine products with other respiratory depressants has an association with resp

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - tylenol® with codeine (acetaminophen and codeine phosphate) tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see warnings ), reserve tylenol® with codeine tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. tylenol® with codeine is contraindicated for: - all children younger than 12 years of age (see warnings ). - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ). tylenol® with codeine is contraindicated in patients with: - significant respiratory depression (see warnings ). - acute or severe bronchial asthma in an unmonitor

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

physicians total care, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - codeine phosphate 10 mg in 5 ml - promethazine with codeine syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. the combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age, because the combination may cause fatal respiratory depression in this age population. codeine is contraindicated in patients with a known hypersensitivity to the drug. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines and codeine are both contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. the combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age. concomitant administration of promethazine products with other respiratory depressants has an association with resp